Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort)Ivan Gentile, Nicola Coppola, Daniela Caterina Amoruso et al.|Hepatology International|2018Cited by 63
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrenceAntonio Riccardo Buonomo, Ivan Gentile, Riccardo Scotto et al.|Medicine|2020Cited by 9